1-17587583-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018125.4(ARHGEF10L):c.161G>A(p.Ser54Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,614,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGEF10L | NM_018125.4 | c.161G>A | p.Ser54Asn | missense_variant | 3/29 | ENST00000361221.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGEF10L | ENST00000361221.8 | c.161G>A | p.Ser54Asn | missense_variant | 3/29 | 1 | NM_018125.4 | A1 | |
ARHGEF10L | ENST00000375415.5 | c.161G>A | p.Ser54Asn | missense_variant | 2/27 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251304Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135804
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727232
GnomAD4 genome AF: 0.000131 AC: 20AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2024 | The c.161G>A (p.S54N) alteration is located in exon 3 (coding exon 2) of the ARHGEF10L gene. This alteration results from a G to A substitution at nucleotide position 161, causing the serine (S) at amino acid position 54 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at